Pharmacological Management of Psychosis in Elderly Patients with Parkinsonism
To access this article, please choose from the options below
Funding: None.
Conflict of Interest: Dr Pandurangi is on the speaker's bureau of Astra-Zeneca, Bristol Myers Squibb, Janssen, and Pfizer Pharmaceuticals. The other authors do not have any potential conflict of interest to disclose.
Authorship: All authors had access to the data and played a role in writing this manuscript.
PII: S0002-9343(09)00166-1
doi:10.1016/j.amjmed.2009.01.025
© 2009 Elsevier Inc. All rights reserved.

